Developing advanced traps and AI to control mosquito populations
Next generation mosquito control through technology-driven trap development and artificial intelligence guided detection of mosquito breeding habitats
This study is all about finding better ways to control mosquitoes that spread diseases like Zika and dengue by using smart traps and technology to spot where they breed, helping to keep our communities healthier and prevent outbreaks before they start.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of South Carolina at Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project ID | NIH-11091679 on NIH RePORTER |
What this research studies
This research focuses on improving mosquito control methods by creating innovative traps and using artificial intelligence to identify mosquito breeding sites. The project aims to enhance the detection and counting of Aedes mosquitoes, which are responsible for spreading diseases like Zika and dengue. By utilizing technology from other fields, the researchers hope to provide more effective and targeted mosquito control strategies, reducing the reliance on reactive insecticide spraying. This approach could lead to better public health outcomes by preventing outbreaks before they occur.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living in areas where Aedes mosquitoes are prevalent and at risk of arboviral infections.
Not a fit: Patients who do not reside in regions affected by Aedes mosquitoes or who are not at risk for arboviral diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence of arboviral diseases transmitted by mosquitoes, improving public health.
How similar studies have performed: Previous research has shown promise in using technology for vector control, indicating that this approach could lead to successful outcomes.
Where this research is happening
Columbia, United States
- University of South Carolina at Columbia — Columbia, United States (Active)
Researchers
- Principal investigator: Nolan, Melissa Suzanne — University of South Carolina at Columbia
- Study coordinator: Nolan, Melissa Suzanne
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.